| http://www.w3.org/ns/prov#value | - ycin (sirolimus or Rapamune) or derivatives thereof.When other therapeutic agents are employed in combination with the compounds of the present invention they may be used for example in amounts as noted in the Physician Desk Reference (PDR) or as otherwise determined by one of ordinary skill in the art.Methods of TreatmentThe compounds of formula I may be used in the treatment of kinase associated
|
